Micromonosporaceae: NCBI 28056, [family]

Back to details

| Actinoplanaceae| Actinoplanaceae Couch 1955| Actinoplanetes| Micromonosporaceae| Micromonosporaceae Krasil'nikov 1938 (Approved Lists 1980) emend Koch et al. 1996| Micromonosporaceae Krasil'nikov 1938 (Approved Lists 1980) emend. Nouioui et al. 2018| Micromonosporaceae Krasil'nikov 1938 (Approved Lists 1980) emend. Stackebrandt et al. 1997| Micromonosporaceae Krasil'nikov 1938 (Approved Lists 1980) emend. Zhi et al. 2009

1. Production of antibiotics: Many members of the Micromonosporaceae family produce antibiotics that have been used clinically to treat bacterial infections in humans. These antibiotics include compounds such as gentamicin, neomycin, and viomycin, which are commonly used to treat a variety of bacterial infections, including those caused by Gram-positive and Gram-negative bacteria.

2. Antibiotic resistance: Despite their efficacy, some bacteria have developed resistance to antibiotics produced by Micromonosporaceae species. Antibiotic resistance is a growing global health concern and poses challenges for the treatment of bacterial infections. Continued research on antibiotic resistance mechanisms and the discovery of new antibiotics from Micromonosporaceae bacteria is important for addressing this issue.

3. Biotechnological applications: Micromonosporaceae bacteria have biotechnological applications beyond antibiotic production. They are also used in the production of enzymes and other bioactive compounds with industrial applications, such as in the food, pharmaceutical, and biotechnology industries. Enzymes produced by Micromonosporaceae bacteria are used in processes such as food fermentation, textile processing, and waste treatment.

4. Ecological interactions: Micromonosporaceae bacteria are found in various environments, including soil, water, and marine sediments. They interact with other microorganisms and their environment in complex ways, influencing ecosystem dynamics and nutrient cycling. Understanding these ecological interactions is important for maintaining ecosystem health and functioning.

5. Rare infections: While Micromonosporaceae bacteria are not typically considered human pathogens, there have been rare reports of infections caused by these bacteria, particularly in immunocompromised individuals or those with underlying health conditions. These infections are often associated with exposure to contaminated environments or medical devices.

Other Sources for more information:

• Immune Epitope Database
• The NCBI taxonomy database
• UniProt
• Immune Epitope Taxonomy Database (IEDB)
• AI Engines For more Details: Perplexity  Kagi Labs  You 

Legend

• The interactions are based on data from 1000 healthy individuals using shotgun 10M reads Precision Biome, a provider in full conformity to EU regulations for health information
• The width of the lines indicates R² (the coefficient of determination)
• Green indicates positive slope
• Red indicates negative
• Interactions are not two way because incidence of each bacteria are different

Micromonosporaceae impacts on other bacteria of the same rank

R2	Slope	Tax Name	Parent Chart

Other bacteria of the same rank impacting Micromonosporaceae

R2	Slope	Tax Name	Parent Chart
0.3612939417362213	0.5346294045448303	Staphylococcaceae	Parent Taxa
0.3567255437374115	0.678235650062561	Paenibacillaceae	Parent Taxa
0.2937387228012085	0.43275871872901917	Lachnospiraceae	Parent Taxa
0.29282623529434204	0.6646031737327576	Brachyspiraceae	Parent Taxa
0.29262205958366394	0.4889797866344452	Treponemataceae	Parent Taxa
0.2677471339702606	0.5301187634468079	Bacillaceae	Parent Taxa
0.26342707872390747	0.3675733506679535	Oscillospiraceae	Parent Taxa
0.2556208074092865	0.4857088625431061	Maliibacteriaceae	Parent Taxa